Mednet Logo
HomeGastroenterology
Gastroenterology

Gastroenterology

Expert perspectives on IBD, liver disease, motility disorders, and GI diagnostic and therapeutic procedures.

Recent Discussions

How does presence of clinically significant portal hypertension change patient prognosis in MASLD?

1
1 Answers

Mednet Member
Mednet Member
Hepatology · Arizona Liver Health

The presence of CSPH based on HVPG or the Baveno criteria (LSM on VCTE + platelet count) indicates higher chances of decompensation. Data from several clinical trials showed that higher VCTE LSM and lower platelet count are associated with higher annual decompensating event rates. Patients with MASH...

When would you consider use of EUS guided liver biopsy over percutaneous and/or transjugular?

2
2 Answers

Mednet Member
Mednet Member
Hepatology · Northwestern

If data (labs, imaging) are not entirely compelling for a primary parenchymal or biliary issue, then EUS liver biopsy can be an efficient approach in addition to ERCP (saving the need for separate biopsy in the event that ERCP is non diagnostic).

How do you rule out spontaneous bacterial peritonitis in a patient with minimal ascites that is not amenable to paracentesis?

1
1 Answers

Mednet Member
Mednet Member
Hospital Medicine · University of Colorado

You can’t, unfortunately. You either need to keep looking for a good pocket (move patient to each side, etc.) or use clinical judgement and decide whether or not to treat empirically.

Do you recommend CBD cessation prior to screening of liver enzymes?

2 Answers

Mednet Member
Mednet Member
Hepatology · Northwestern Memorial Hospital

CBD increases liver enzymes. In a study, it took 1-2 weeks to normalize after cessation. Would recommend ideally 2 weeks, but a minimum of 1 week to remove the noise caused by CBD that may lead to an extensive and possibly unnecessary workup.

How do you approach the management of patients who require nutritional restoration in the setting of a presumed functional GI disorder recalcitrant to behavioral medicine and pharmacologic therapies?

1
2 Answers

Mednet Member
Mednet Member
Gastroenterology · Beitman Robert G Office

It certainly is a very good question if indeed the patient has functional disease; then, for sure, they need more than just my help. They probably need the help of a nutritionist, but even more so, they need perhaps psychiatric medication and the treatment of a behavioral therapist or psychological ...

Do you avoid the use of GLP-1 R agonist therapy for treatment of obesity in patients with known gastroparesis?

1
1 Answers

Mednet Member
Mednet Member
Endocrinology · Brigham And Womens Hospital Endocrinology

Short answer: yes. Gastroparesis is a well-known side effect of GLP-1 RA therapy. It is dose-dependent, so some patients may tolerate smaller doses but not the highest ones. A recent head-to-head trial of semaglutide vs tirzepatide in obesity (Aronne et al., PMID 40353578) found similar rates of gas...

How would you manage long-segment Barrett's esophagus with both LGD and HGD that has failed to respond to RFA, cryoablation, or even Nissen fundoplication for large hiatal hernia?

2
3 Answers

Mednet Member
Mednet Member
Gastroenterology · University of Arizona

ESD/multifocal EMR followed by may be a great option to assess T-stage/rule out occult esophageal cancer. However, the challenge with a large hiatal hernia is ongoing severe GERD and persistent esophagitis. This is a known risk factor for lack of response to endoscopic ablative and resection therapi...

When giving albumin challenge, for acute kidney injury with suspected hepatorenal syndrome, do you administer a single dose daily or split the dose of albumin?

2
1 Answers

Mednet Member
Mednet Member
Hepatology · UCLA

The main concern about albumin infusions is the potential risk for pulmonary edema (China et al., PMID 33657293). Therefore, I prefer to have albumin administered in divided doses of 25 grams at a time with a max daily dose of up to 100 grams, and I tend to stop IV albumin if the serum albumin level...

Do you feel there is a role for triple-phase budesonide in the management of patients with celiac disease who refuse to follow a gluten free diet?

1
1 Answers

Mednet Member
Mednet Member
Gastroenterology · Harvard Medical School

I do not believe it does. Budesonide is useful for acute gluten exposures and type 1 RCD but will not correct the inflammatory cascade associated with chronic gluten exposure and has significant side effects with long term use.

How do you approach managing depression symptoms in patients who have had repeated high risk of bleeding?

6
2 Answers

Mednet Member
Mednet Member
Psychiatry · University of Colorado

Overall, evidence suggests that while SSRIs do increase the risk of bleeding. The absolute risk of a bleeding event remains low and is usually not serious. A 2017 meta-analysis by Laporte et al., suggested that overall bleeding risk is increased by at least 36% while other meta-analyses suggest that...